Prevention in action: prevention in the joint action on respiratory diseaseers

Prof. Ildiko Horvath share her thoughts on prevention in the joint action on respiratory disease at ERS Congress 2025.

Current controversies in interstitial lung diseases

Prof. Catharina Moor co-chaired a very interesting session at this year's ERS congress on the current controversies in interstitial lung diseases.

The emerging therapeutic interventions for the management of interstitial lung diseases

Prof. Michael Kreuter co-chaired a very interesting session at this year's ERS congress on the emerging therapeutic interventions for the management of interstitial lung diseases.

Addressing the generational challenge in lung health amidst the growing number of novel tobacco products

Prof. Andrew Bush share his thoughts on the generational challenge in lung health amidst the growing number of novel tobacco products at ERS Congress 2025.

Horizon scanning in the treatment of interstitial lung diseases

Dr. Nazia Chaudhuri co-chaired a very interesting session at this year's ERS congress on horizon scanning in the treatment of interstitial lung diseases.

Advancing lung cancer care with real-world evidence, artificial intelligence and computerised clinical guidelines

Prof. Job F.M. van Boven co-chaired a very interesting session at this year's ERS congress on advancing lung cancer care with real-world evidence, artificial intelligence and computerised clinical guidelines.

Thoracic oncology - Lung cancer screening updates: switch gears to move forward

Prof. Andriani Charpidou co-chaired a very interesting session at this year's ERS congress on lung cancer screening updates.

Unmasking COPD: Recognizing Early Signs and Tailoring Treatment

Professor Federico Lavorini share his thoughts on the power of personalized inhalers at this year's ERS congress.

Epidemiology of asthma, including severe asthma

Prof. Joan B. Soriano co-chaired a very interesting session at this year's ERS congress on the epidemiology of asthma, including severe asthma.

Unlocking new pathways: emerging therapeutic targets in asthma and COPD

Prof. Ian M. Adcock co-chaired a very interesting session at this year's ERS congress on the emerging therapeutic targets in asthma and COPD.

Severe asthma: from the underlying mechanism to clinical remission

Prof. Fabio Ricciardolo co-chaired a very interesting session at this year's ERS congress on severe asthma, from the underlying mechanism to clinical remission.

Real-life effectiveness of aclidinium/formoterol in COPD control: preliminary results of the REDACT observational study

Prof. Konstantinos Kostikas share his thoughts on the real-life effectiveness of aclidinium/formoterol in COPD control at ERS Congress 2025.

Benefits of twice daily inhaler dosage in the treatment of COPD

Prof. Claus Vogelmeier share his thoughts on the benefits of twice daily inhaler dosage in the treatment of COPD at ERS Congress 2025.

Lung cancer and severe respiratory comorbidities: navigating complex clinical challenges

Understanding aging mechanisms and their effect in asthma

Dr. Stefania Principe share her thoughts on the understanding aging mechanisms and their effect in asthma at ERS Congress 2025.